J

Jagath R. Junutula

Chrono Therapeutics (United States)

ORCID: 0000-0002-5942-4428

Publishes on HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Cellular transport and secretion. 82 papers and 7.8k citations.

PubIndex Score97Top 3%How it's scored

82Publications

7.8kTotal Citations

First publication: 1997First senior author: 2010

HER2/EGFR in Cancer Research Monoclonal and Polyclonal Antibodies Research Cellular transport and secretion Click Chemistry and Applications Radiopharmaceutical Chemistry and Applications

Top publicationsby citations

Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index

Jagath R. Junutula, William Mallet, Siao Ping Tsai et al.|Nature Biotechnology|2008

Cited by 1.4k

Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates

Ben‐Quan Shen, Jagath R. Junutula, Keyang Xu et al.|Nature Biotechnology|2012

Cited by 997

An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody–Drug Conjugate for the Treatment of Hormone Receptor–Positive Breast Cancer

Sunil Bhakta, Jagath R. Junutula|Molecular Cancer Therapeutics|2017

Cited by 31

An improved and robust DNA immunization method to develop antibodies against extra-cellular loops of multi-transmembrane proteins

Meredith Hazen, Jo-Anne Hongo, Sunil Bhakta et al.|mAbs|2013

Cited by 28